Alterations in EGFR in the form of overexpression, amplification, or mutations are postulated to contribute to the development or propagation of lung cancer by enhancing cellular proliferation, apoptosis inhibition, and angiogenesis (Ciardiello and Tortora, 2003; Gazdar, 2009). The gene discussed is EGFR; the disease is lung cancer.